Anzeige
Mehr »
Sonntag, 15.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
105 Leser
Artikel bewerten:
(0)

If you purchased Skechers' footwear called Shape-ups, Resistance Runner, Shape-ups Toners/Trainers, or Tone-ups between August 1, 2008 and August 13, 2012 in the United States, your rights may be affected by a proposed class action settlement

SAN DIEGO, Sept. 9, 2012 /PRNewswire/ -- The following statement is being issued by Blood Hurst & O'Reardon, LLP regarding the Skechers proposed class action settlement.

Legal Notice

If you purchased Skechers' footwear called Shape-ups, Resistance Runner, Shape-ups Toners/Trainers, or Tone-ups between August 1, 2008 and August 13, 2012 in the United States, your rights may be affected by a proposed class action settlement.

A settlement has been proposed in a class action lawsuit regarding the following toning footwear categories: (a) Shape-ups rocker bottom shoes ("Shape-ups"); (b) Resistance Runner rocker bottom shoes ("Resistance Runner"); (c) Shape-ups Toners/Trainers, and Tone-ups with podded outsoles ("Podded Sole Shoes"); and (d) Tone-ups non-podded sandals, boots, clogs, and trainers ("Tone-ups (Non-Podded Sole)") sold by Skechers (the "Eligible Shoes"). The Court in Grabowski v. Skechers U.S.A., Inc., No. 3:12-cv-00204 (W.D. Ky.) will hold a final approval hearing on March 19, 2013.

ARE YOU AFFECTED?

You are a Class Member and may be eligible to receive a payment if you purchased any of the Eligible Shoes in the United States from August 1, 2008 to August 13, 2012 inclusive, with limited exclusions.

WHAT IS THIS CASE ABOUT?

The lawsuit alleges that Skechers violated certain state laws regarding the marketing and sale of toning shoes between August 1, 2008, until and including August 13, 2012. Skechers expressly denies any wrongdoing and does not admit or concede any actual or potential fault, wrongdoing, or liability in connection with any facts or claims that have been alleged against it. Specifically, Skechers contends that fitness benefits of Shape-ups and other rocker bottom shoes have been extensively studied and confirmed in numerous well-designed clinical studies, many of which have been published in peer-reviewed journals. Skechers contends that this body of scientific literature and experts in the field of biomechanics confirm that competent and reliable scientific evidence supports fitness benefits for those shoes. The Court did not decide which side was right. Instead, the Parties have decided to settle. The Parties believe the proposed settlement is fair, reasonable, and adequate and will provide substantial benefit to the Class.

WHAT DOES THIS SETTLEMENT PROVIDE?

The settlement provides a fund of $40 million, less the costs of notice and settlement administration, to pay claims to eligible Class Members relating to the purchase of Eligible Shoes. The Settlement Agreement is found at www.Skecherssettlement.com. Skechers also agrees to make certain conduct changes and separately pay Attorneys' Fees and Expenses and class representative awards.

HOW DO YOU ASK FOR A PAYMENT?

To be eligible for a payment, Class Members must send in a completed Claim Form electronically submitted no later than April 18, 2013 or postmarked no later than April 18, 2013. Payment amounts to eligible Class Members will vary depending upon, among other factors, the product(s) purchased, the number and amounts claimed by all Class Members and other adjustments and deductions. The amount could be more (up to double), the same, or less than $40.00 for Shape-ups, $42.00 for Resistance Runner, $27.00 for Podded Sole Shoes, and $20.00 for Tone-ups (Non-Podded Sole).

WHAT ARE YOUR OPTIONS?

If you are a Class Member, you may (1) do nothing; (2) exclude yourself; (3) send in a Claim Form; and/or (4) object to the settlement.

If you don't want to be bound by the settlement, you must exclude yourself by letter postmarked by January 14, 2013. If you exclude yourself, you can't get a payment from this settlement or object to the settlement, but you can sue Skechers for these claims. If you stay in the Class, you may submit a Claim Form and/or object to the settlement. Claim Forms must be submitted to the Claims Administrator by April 18, 2013. Objections must be filed with the Court by January 14, 2013. The detailed notice describes how to file a Claim, object, or exclude yourself and provides other important information. The Court will hold a hearing in this case on March 19, 2013 at 1:00 p.m. ET at the United States District Court for the Western District of Kentucky, 601 West Broadway, Louisville, Kentucky 40202-2227, to consider final approval of the settlement, payment of Attorneys' Fees and Expenses of up to $5 million, payments of up to $2,500 for each of the two named Plaintiffs, and related issues. You may appear at the hearing, but you don't have to.

HOW CAN YOU GET A CLAIM FORM OR MORE INFORMATION?

To obtain a detailed notice, Claim Form or other documents, visit www.Skecherssettlement.com or call, toll-free, (866) 325-4186, or write to Administrator, PO Box 2008, Chanhassen, MN 55317-2008.

SOURCE GCG

© 2012 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.